These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39305896)

  • 1. Approval of the first TCR-based cell therapy.
    Singh N
    Mol Ther; 2024 Oct; 32(10):3195. PubMed ID: 39305896
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in CAR T-cell therapy for chronic lymphocytic leukemia.
    Porter DL
    Clin Adv Hematol Oncol; 2018 Feb; 16(2):118-120. PubMed ID: 29741512
    [No Abstract]   [Full Text] [Related]  

  • 3. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition.
    Houot R; Schultz LM; Marabelle A; Kohrt H
    Cancer Immunol Res; 2015 Oct; 3(10):1115-22. PubMed ID: 26438444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric antigen receptor T cell therapy: 25years in the making.
    Gill S; Maus MV; Porter DL
    Blood Rev; 2016 May; 30(3):157-67. PubMed ID: 26574053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA approves first TCR-engineered T cell therapy, for rare soft-tissue cancer.
    Mullard A
    Nat Rev Drug Discov; 2024 Oct; 23(10):731. PubMed ID: 39152243
    [No Abstract]   [Full Text] [Related]  

  • 6. Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy.
    Rath JA; Arber C
    Cells; 2020 Jun; 9(6):. PubMed ID: 32570906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in T-cell Immunotherapies.
    Stroncek DF; Reddy O; Highfill S; Panch SR
    Hematol Oncol Clin North Am; 2019 Oct; 33(5):825-837. PubMed ID: 31466607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy.
    Foster JB; Barrett DM; Karikó K
    Mol Ther; 2019 Apr; 27(4):747-756. PubMed ID: 30819612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serving "a la CAR-T": Value-Based Pricing and Gene Therapy.
    Tempero M
    J Natl Compr Canc Netw; 2017 Oct; 15(10):1179. PubMed ID: 28982741
    [No Abstract]   [Full Text] [Related]  

  • 10. From CARs to TRUCKs and Beyond: Safely en Route to Adoptive T-cell Therapy for Cancer.
    Dummy
    EBioMedicine; 2016 Dec; 14():1-2. PubMed ID: 27986279
    [No Abstract]   [Full Text] [Related]  

  • 11. Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor.
    van den Berg JH; Gomez-Eerland R; van de Wiel B; Hulshoff L; van den Broek D; Bins A; Tan HL; Harper JV; Hassan NJ; Jakobsen BK; Jorritsma A; Blank CU; Schumacher TN; Haanen JB
    Mol Ther; 2015 Sep; 23(9):1541-50. PubMed ID: 25896248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered cell therapy for cancer gets thumbs up from FDA advisers.
    Ledford H
    Nature; 2017 Jul; 547(7663):270. PubMed ID: 28726836
    [No Abstract]   [Full Text] [Related]  

  • 13. Modelling CAR-T therapy in humanized mice.
    Wu Y; Yu XZ
    EBioMedicine; 2019 Feb; 40():25-26. PubMed ID: 30665855
    [No Abstract]   [Full Text] [Related]  

  • 14. Next Steps in the CAR Journey of a Thousand Miles.
    Brenner MK
    Mol Ther; 2017 Oct; 25(10):2226-2227. PubMed ID: 28939089
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances in off-the-shelf CAR T-cell therapy.
    Benjamin R
    Clin Adv Hematol Oncol; 2019 Mar; 17(3):155-157. PubMed ID: 30969953
    [No Abstract]   [Full Text] [Related]  

  • 16. Armed T cells with CAR for cancer immunotherapy.
    Wei YQ
    Sci China Life Sci; 2016 Apr; 59(4):331-2. PubMed ID: 27080712
    [No Abstract]   [Full Text] [Related]  

  • 17. Of chimeric antigen receptors and antibodies: OX40 and 41BB costimulation sharpen up T cell-based immunotherapy of cancer.
    Hombach AA; Abken H
    Immunotherapy; 2013 Jul; 5(7):677-81. PubMed ID: 23829616
    [No Abstract]   [Full Text] [Related]  

  • 18. TCR-engineered, customized, antitumor T cells for cancer immunotherapy: advantages and limitations.
    Chhabra A
    ScientificWorldJournal; 2011 Jan; 11():121-9. PubMed ID: 21218269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAR T-cell therapy against B-cell maturation antigen in multiple myeloma.
    Cohen AD
    Clin Adv Hematol Oncol; 2018 Dec; 16(12):804-806. PubMed ID: 30843888
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy for Glioblastoma: Adoptive T-cell Strategies.
    Choi BD; Maus MV; June CH; Sampson JH
    Clin Cancer Res; 2019 Apr; 25(7):2042-2048. PubMed ID: 30446589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.